{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:12:46Z","timestamp":1648617166464},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/bega.2002.0350","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T20:48:30Z","timestamp":1039553310000},"page":"811-833","source":"Crossref","is-referenced-by-count":2,"title":["Oesophageal disorders: future developments"],"prefix":"10.1053","volume":"16","author":[{"given":"William","family":"Tam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Dent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2002.0350_RF1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.44.2008.S1","article-title":"An evidence-based appraisal of reflux disease management \u2013 the Genval Workshop Report","volume":"44","author":"Dent","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF3","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1572-0241.1998.00594.x","article-title":"The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms","volume":"93","author":"Blustein","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1572-0241.2001.03451.x","article-title":"Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease","volume":"96","author":"Shaw","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","article-title":"Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","article-title":"Esomeprazole (40mg) compared with lansoprazole (30mg) in the treatment of erosive esophagitis","volume":"97","author":"Castell","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00365529309096057","article-title":"Interobserver variation in the endoscopic diagnosis of reflux esophagitis","volume":"28","author":"Bytzer","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF9","doi-asserted-by":"crossref","unstructured":"Vieth, M, Delarive, J, Dent, J, Red streaks in the oesophagus in patients with reflux oesophagitis: what are the histomorphological correlates?, Scandinavian Journal of Gastroenterology, 2001, 36(11), 1123, 1127","DOI":"10.1080\/00365520152584725"},{"key":"10.1053\/bega.2002.0350_RF10","doi-asserted-by":"crossref","first-page":"AB119","DOI":"10.1016\/S0016-5107(01)80219-4","article-title":"Proposed new endoscopic criteria for minimal change reflux esophagitis based on magnification endoscopy","volume":"53","author":"Tam","year":"2001","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF11","first-page":"A-74","article-title":"Endoscopy-negative reflux disease (ENRD): high-resolution endoscopic and histological signs","volume":"122","author":"Tam","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.38.5.649","article-title":"Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis","volume":"38","author":"Holloway","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1365-2036.2001.01087.x","article-title":"Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole","volume":"15","author":"Andersson","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF14","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1365-2036.2001.01128.x","article-title":"Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis","volume":"15","author":"Edwards","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1440-1746.2001.02617.x","article-title":"Reflux esophagitis: effect of position, nocturnal acid reflux","volume":"16","author":"Adachi","year":"2001","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2002.0350_RF16","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1572-0241.2001.03861.x","article-title":"Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies [erratum appears in Am J Gastroenterol 2001; 96: 2809]","volume":"96","author":"Howden","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/gast.2001.28649","article-title":"Step-down management of gastroesophageal reflux disease","volume":"121","author":"Inadomi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2036.2002.01167.x","article-title":"The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease","volume":"16","author":"Ofman","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF19","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1001\/jama.285.18.2376","article-title":"Surgical therapy for reflux disease","volume":"285","author":"Kahrilas","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.2002.0350_RF20","first-page":"29","article-title":"How satisfied are chronic heartburn sufferers with their prescription medications? Results of the unmet needs survey","volume":"7(11)","author":"Crawley","year":"2000","journal-title":"J Clin Outcomes Management"},{"key":"10.1053\/bega.2002.0350_RF21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000048863","article-title":"Effects of very long (up to 10 year) proton pump blockade on human gastric mucosa","volume":"64","author":"Lamberts","year":"2001","journal-title":"Digestion"},{"key":"10.1053\/bega.2002.0350_RF23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/gast.2001.27098","article-title":"Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole","volume":"121","author":"Vermeer","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/gast.2002.32963","article-title":"Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction","volume":"122","author":"Iijima","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF25","first-page":"101","article-title":"Symptomatic benefit 1\u20133 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease","volume":"95","author":"McColl","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF26","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","article-title":"The effect of population H. pylori screening and treatment on dyspepsia and quality of life in the community: results of a randomised controlled trial","volume":"355","author":"Moayyedi","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0350_RF27","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2001.29332","article-title":"Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease","volume":"121","author":"Moayyedi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2036.2001.00103.x","article-title":"Is Helicobacter pylori relevant in the management of reflux disease [review]?","volume":"15","author":"Dent","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.2000.00758.x","article-title":"High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis","volume":"14","author":"Hamada","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2036.2000.00714.x","article-title":"Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease","volume":"14","author":"Wu","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2036.1998.00310.x","article-title":"Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease","volume":"12","author":"Stolte","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF32","doi-asserted-by":"crossref","first-page":"A-14","DOI":"10.1016\/S0016-5085(08)80069-8","article-title":"Helicobacter pylori eradication for the prevention of atrophic gastritis during omeprazole therapy: a prospective randomized trial","volume":"120","author":"Kuipers","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection \u2013 the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF34","first-page":"233","article-title":"Current status of acid pump antagonists (reversible PPIs)","volume":"69","author":"Wurst","year":"1996","journal-title":"Yale Journal of Biology and Medicine"},{"key":"10.1053\/bega.2002.0350_RF35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/gast.2000.20191","article-title":"Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations","volume":"119","author":"Van Herwaarden","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2036.2002.01153.x","article-title":"Review article: transient lower oesophageal sphincter relaxations \u2013 a pharmacological target for gastro-oesophageal reflux disease?","volume":"16","author":"Hirsch","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gut.50.1.6","article-title":"Anti-relaxation therapy in GORD","volume":"50","author":"Tack","year":"2002","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(00)70408-2","article-title":"Control of transient lower esophageal sphincter relaxations and gastroesophageal reflux by the GABAB agonist baclofen in normal subjects","volume":"118","author":"Lidums","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.50.1.19","article-title":"Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease","volume":"50","author":"Zhang","year":"2002","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2036.2001.01045.x","article-title":"The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease","volume":"15","author":"Trudgill","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2002.0350_RF41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archsurg.136.2.180","article-title":"Laparoscopic Nissen fundoplication. Five-year results and beyond","volume":"136","author":"Lafullarde","year":"2001","journal-title":"Archives of Surgery"},{"key":"10.1053\/bega.2002.0350_RF42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1091-255X(01)80012-3","article-title":"Five- to eight-year outcome of the first laparoscopic Nissen fundoplications","volume":"5","author":"Bammer","year":"2001","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1053\/bega.2002.0350_RF43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1072-7515(00)00797-3","article-title":"Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gatsroesophageal reflux disease","volume":"192","author":"Lundell","year":"2001","journal-title":"Journal of the American College of Surgeons"},{"key":"10.1053\/bega.2002.0350_RF44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(99)03097-4","article-title":"Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial","volume":"355","author":"Bais","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0350_RF45","unstructured":"Vakil, N, Treml, S, Shaw, M, Kirby, R, The outcome of laparoscopic fundoplication for reflux diseases in community practice in the USA, American Journal of Medicine"},{"key":"10.1053\/bega.2002.0350_RF46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1067\/mge.2001.113502","article-title":"Transoral, flexible endoscopic suturing for treatment of GERD: a multi-center trial","volume":"53","author":"Filipi","year":"2001","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF47","first-page":"A-47","article-title":"Impact of endoscopic suturing of the gastroesophageal junction on lower esophageal sphincter function and gastroesophageal reflux in patients with reflux disease","volume":"122","author":"Tam","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1067\/mge.2002.121227","article-title":"The Stretta procedure for the treatment of GERD: 6and 12 month follow-up of the U.S. open label trial","volume":"55","author":"Triadafilopoulos","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF49","first-page":"AB100","article-title":"Radiofrequency energy to the gastroesophageal junction for treatment of GERD (the Stretta procedure): a randomized, sham-controlled, multi-center clinical trial [abstract]","volume":"55","author":"Corley","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF50","first-page":"AB 860","article-title":"Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation in a canine model [abstract]","volume":"118","author":"Kim","year":"2000","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF51","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1572-0241.2002.05597.x","article-title":"Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action","volume":"97","author":"DiBaise","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF52","doi-asserted-by":"crossref","first-page":"A-16","DOI":"10.1016\/S0016-5085(08)80079-0","article-title":"Delivery of radiofrequency energy (RFe) to the lower esophageal sphincter (LES) and gastric cardia inhibits transient LES relaxations and gastroesophageal reflux in patients with reflux disease [abstract]","volume":"120","author":"Tam","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1067\/mge.2001.113912","article-title":"Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD","volume":"43","author":"Feretis","year":"2001","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s004640080189","article-title":"Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model","volume":"16","author":"Mason","year":"2002","journal-title":"Surgical Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF55","first-page":"AB101","article-title":"Enteryx solution, a minimally invasive injectable treatment for GERD: international multicenter trial results","volume":"55","author":"Lehman","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF56","first-page":"AB90","article-title":"Endoscopic augmentation of the lower esophageal sphincter (LES) for the treatment of GERD: multicenter study of the Gatekeeper reflux repair system","volume":"55","author":"Fockens","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01537229","article-title":"Lack of impact of therapy on extent of Barrett's esophagus in 67 patients","volume":"35","author":"Sampliner","year":"1990","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2002.0350_RF58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mge.2002.123420","article-title":"Classification of Barrett's epithelium by magnifying endoscopy","volume":"55","author":"Endo","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1067\/mge.2001.115728","article-title":"Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus","volume":"54","author":"Sharma","year":"2001","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF60","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/gut.49.6.746","article-title":"The continuing tale of cytokeratins in Barrett's mucosa: as you like it","volume":"49","author":"Latchford","year":"2001","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF61","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/gast.2001.27215","article-title":"Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa","volume":"121","author":"El-Rifai","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4065\/76.3.331","article-title":"Short segment Barrett esophagus and specialized columnar mucosa at the gastroesophageal junction","volume":"76","author":"Sharma","year":"2001","journal-title":"Mayo Clinical Proceedings"},{"key":"10.1053\/bega.2002.0350_RF63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0016-5085(99)70123-X","article-title":"Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data","volume":"116","author":"Hirota","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF64","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1111\/j.1572-0241.2001.05262.x","article-title":"Short-segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia","volume":"96","author":"Benipal","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF65","first-page":"407","article-title":"Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus","volume":"92","author":"Weston","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.7326\/0003-4819-132-8-200004180-00003","article-title":"Effect of segment length on risk for progression in patients with Barrett's esophagus","volume":"132","author":"Rudolph","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2002.0350_RF67","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1572-0241.2000.02234.x","article-title":"Long-term follow-up of Barrett's high-grade dysplasia","volume":"95","author":"Weston","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00042737-200202000-00004","article-title":"Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s","volume":"14","author":"Wijnhoven","year":"2002","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2002.0350_RF69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00042737-200202000-00001","article-title":"Counting cancers at the junction \u2013 a problem of routine statistics","volume":"14","author":"Forman","year":"2002","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2002.0350_RF70","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/gast.2002.31599","article-title":"Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West","volume":"122","author":"Jankowski","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/gast.2000.9849","article-title":"Barrett's esophagus: an overrated cancer risk factor","volume":"119","author":"Spechler","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.50.3.368","article-title":"Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA","volume":"50","author":"El-Serag","year":"2002","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF73","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1046\/j.1440-1746.17.s1.8.x","article-title":"New optical technologies for earlier endoscopic diagnosis of premalignant gastrointestinal lesions","volume":"17","author":"Dacosta","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2002.0350_RF74","first-page":"A289","article-title":"Detection of cytogenetic abnormalities by multi-color FISH in brush cytology specimens of Barrett's esophagus","volume":"122","author":"Krishnadath","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4065\/76.4.438","article-title":"Biomarkers in Barrett esophagus","volume":"76","author":"Krishnadath","year":"2001","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/bega.2002.0350_RF76","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/gast.2002.31879","article-title":"Surveillance and survival in Barrett's adenocarcinomas: a population-based study","volume":"122","author":"Corley","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/gast.2002.30297","article-title":"Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review","volume":"122","author":"Dulai","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF78","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2002.0350_RF79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","article-title":"Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure","volume":"118","author":"Shirvani","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF80","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2001.29569","article-title":"Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery","volume":"121","author":"Ye","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF81","first-page":"1322","article-title":"Aspirin use and risk of fatal cancer","volume":"53","author":"Thun","year":"1993","journal-title":"Cancer Research"},{"key":"10.1053\/bega.2002.0350_RF82","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","article-title":"Aspirin and reduced risk of esophageal carcinoma","volume":"76","author":"Funkhouser","year":"1995","journal-title":"Cancer"},{"key":"10.1053\/bega.2002.0350_RF83","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow","year":"1998","journal-title":"Cancer, Epidemiology, Biomarkers and Prevention"},{"key":"10.1053\/bega.2002.0350_RF84","first-page":"545","article-title":"Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention","volume":"9","author":"Li","year":"2000","journal-title":"Cancer, Epidemiology, Biomarkers and Prevention"},{"key":"10.1053\/bega.2002.0350_RF85","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells","volume":"60","author":"Souza","year":"2000","journal-title":"Cancer Research"},{"key":"10.1053\/bega.2002.0350_RF86","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence","volume":"96","author":"Morris","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF87","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF88","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","volume":"93","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF89","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","article-title":"Barrett's esophagus: a new look at surveillance based on emerging rates of cancer risk","volume":"94","author":"Provenzale","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0350_RF90","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1067\/mge.2001.114418","article-title":"Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study","volume":"53","author":"Sampliner","year":"2001","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.2002.0350_RF91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.49.1.142","article-title":"Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy","volume":"49","author":"Fennerty","year":"2001","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF92","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gut.46.4.574","article-title":"Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus","volume":"46","author":"Van Laethem","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0350_RF93","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.48.4.580b","article-title":"Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation","volume":"48","author":"Shand","year":"2001","journal-title":"Gut"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691802903501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691802903501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:53:32Z","timestamp":1583927612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691802903501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521691802903501"],"URL":"https:\/\/doi.org\/10.1053\/bega.2002.0350","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}